|
Volumn 70, Issue , 2000, Pages 1616-1624
|
Efficient gene delivery to vascular smooth muscle cells using a nontoxic, synthetic peptide vector system targeted to membrane integrins: A first step toward the gene therapy of chronic rejection
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CATION;
CHLOROQUINE;
DNA;
HEMAGGLUTININ;
INTEGRIN;
LIPID;
POLYLYSINE;
SYNTHETIC PEPTIDE;
ALLOGRAFT;
AMINO TERMINAL SEQUENCE;
ANIMAL TISSUE;
ARTICLE;
CELL CULTURE;
CONTROLLED STUDY;
DNA VECTOR;
ENDOCYTOSIS;
GENE TARGETING;
GENE THERAPY;
GENETIC TRANSFECTION;
GRAFT REJECTION;
HISTOPATHOLOGY;
HUMAN;
HUMAN TISSUE;
INFLUENZA VIRUS;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN DNA BINDING;
PROTEIN DOMAIN;
RABBIT;
RAT;
SMOOTH MUSCLE FIBER;
VASCULAR SMOOTH MUSCLE;
ANIMALS;
CHRONIC DISEASE;
GENE THERAPY;
GENE TRANSFER TECHNIQUES;
GENETIC VECTORS;
GRAFT REJECTION;
HUMANS;
INTEGRINS;
MUSCLE, SMOOTH, VASCULAR;
OLIGOPEPTIDES;
POLYLYSINE;
RABBITS;
RATS;
|
EID: 0034671076
PISSN: 00411337
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(00)02155-2 Document Type: Article |
Times cited : (22)
|
References (31)
|